Showing results (31-40 of 2,842) with videos related to

Sort By:
Pageof 285
European Journal of Immunology|March 1, 1985
T helper cell recognition of idiotopes on lambda 2 light chains of M315 and T952: evidence for dependence on somatic mutations in the third hypervariable regionB Bogen, T Jørgensen, K Hannestad
Scandinavian Journal of Immunology|June 1, 1993
T-cell receptor alpha haplotype influences V alpha epitope expression on both cortisone-resistant thymocytes and lymph node T cellsB Bogen, L Gleditsch, A Teig
European Journal of Immunology|November 1, 1986
Idiotope-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II moleculesB Bogen, B Malissen, W Haas
Scandinavian Journal of Immunology|March 11, 2011
Is secretion of tumour-specific antigen important for cancer eradication by CD4(+) T cells?--Implications for cancer immunotherapy by adoptive T cell transferA Corthay, K B Lorvik, B Bogen
European Journal of Immunology|December 22, 1999
Resting small B cells present endogenous immunoglobulin variable-region determinants to idiotope-specific CD4(+) T cells in vivoL A Munthe, J A Kyte, B Bogen
Clinical and Experimental Immunology|November 1, 1982
Monoclonal hybridoma antibodies to human amyloid related protein SAAG Marhaug, G Gaudernack, B Bogen, et al.
Scandinavian Journal of Immunology|July 12, 2013
A public T cell receptor recognized by a monoclonal antibody specific for the D-J junction of the β-chainT Frigstad, G Å Løset, I Sandlie, et al.
Scandinavian Journal of Immunology|September 30, 2011
Generation of antibody-producing hybridomas following one single immunization with a targeted DNA vaccineI Øynebråten, T-O Løvås, K Thompson, et al.
Acta Oncologica (Stockholm, Sweden)|January 6, 2001
Deletion of idiotype (Id)-specific T cells in multiple myelomaB Bogen, K Schenck, L A Munthe, et al.
Scandinavian Journal of Immunology|July 9, 2004
Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic miceZ Dembic, P O Hofgaard, H Omholt, et al.
Pageof 285